US biotech to apply artificial intelligence to UK genome study

 (iStockphoto) Berg, a private company that uses artificial intelligence to discover new drugs and diagnostics, will help England’s national genomics project mine DNA and health data from thousands of British citizens for potential drug targets.  Berg, based in Boston, was co-founded in 2006 by Silicon Valley real estate billionaire Carl Berg. Since then, it has been working to change the way drugs are discovered, working in partnership with key players such as the U.S. Department of Defense and the Parkinson’s Institute Clinical Center. Its newest agreement is with the Genomics England 100,000 Genomes Project, which aims to accelerate development of new diagnostics and treatments through a year-long industry trial, company executives told Reuters. The project focuses on patients with rare diseases and six common cancers. Industry partners include drugmakers such…


Link to Full Article: US biotech to apply artificial intelligence to UK genome study